Andrea Rosinus

Title: Andrea Rosinus: Innovator in Estrogen-Dependent Disease Treatment

Introduction

Andrea Rosinus is a notable inventor based in Munich, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for estrogen-dependent diseases. Her innovative work has led to the creation of a patent that addresses critical health issues.

Latest Patents

Andrea holds a patent for "2-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of 17β-hydroxy steroid dehydrogenase type 1." This invention relates to new 2-substituted estra-1,3,5(10)-trien-17-ones of formula I, along with their pharmaceutically acceptable salts. The patent outlines methods of manufacture and use as medicaments for the prophylaxis and therapy of estrogen-dependent diseases that can be influenced by the inhibition of 17β-hydroxy steroid dehydrogenase type 1. She has 1 patent to her name.

Career Highlights

Andrea is currently associated with Schering Aktiengesellschaft, a company known for its focus on pharmaceuticals and healthcare. Her work at the company has been instrumental in advancing research and development in the field of hormone-related therapies.

Collaborations

Throughout her career, Andrea has collaborated with esteemed colleagues, including Alexander Hillisch and Olaf Peters. These partnerships have fostered innovation and have contributed to the success of her projects.

Conclusion

Andrea Rosinus is a pioneering inventor whose work in the field of estrogen-dependent diseases has the potential to make a significant impact on healthcare. Her dedication to innovation and collaboration continues to drive advancements in medicinal chemistry.